Lobe Sciences Announces Changes to Board of Directors
Appointment of Michael Petter to the Board brings another seasoned board member with strong industry, capital markets and strategic planning expertise.
Vancouver, British Columbia–(Newsfile Corp. – January 8, 2021) – Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company“) is pleased to announce the appointment of Mr. Michael Petter as an independent director to the Company’s Board of Directors, effective immediately. Mr. Petter replaces Thomas Baird, who resigned from the Company’s Board of Directors effective today, but still remains CEO of the Company.
Michael Petter is an accomplished leader and entrepreneur with significant experience in the psychedelics and cannabis industry, co-founding and acting as a director of several companies that successfully completed M&A transactions. He holds a Bachelors in Computer Science from London University, is a Chartered Engineer and private pilot. Since January 2009, he has been the Managing Director of Eyvo eProcurement Solutions, a US-based private company that is a leading eProcurement provider in the SaaS space. He also runs a business mentoring program that assists businesses and individuals with change management.
Mr. Petter has significant psychedelic and cannabis industry expertise. Mike was co-founder and director of Eleusian Biosciences Corp., which the Company acquired in July 2020. He also co-founded and was a director of Tassili Life Sciences Corp. which was acquired by CSE-listed Champignon Brands Inc. in March 2020. Mr. Petter has independent board experience being chairman of a compensation committee and as a member of an audit committee. His executive advisory skills focus on providing guidance on strategy, operations, finance and logistics.
Jonathan Gilbert, Executive Chairman of Lobe states, “We are extremely pleased to have Mike join our team with his extensive leadership and industry expertise. I have had the privilege of working with him co-founding several companies including Tassili and Eleusian. Michael is a successful businessman and his experience as a seasoned board member in our industry will be extremely valuable to the Company as we continue to drive innovation, and strive to be a leader in this exciting and emerging industry.”
The Company would also like to thank Mr. Baird for his contributions to the Board of Directors.
About Lobe Sciences Ltd.
Lobe is a growth-oriented research, technology & services company that provides financial, management, IP and branding support to businesses. The Company operates a portfolio of companies focused on developing transformational medicines and applies refined strategies to help partner companies reach their full potential. Based in Vancouver, BC, Lobe Sciences creates value through acquisitions and development of assets, products and technologies by leveraging its scientific, engineering, branding and operational expertise supported by strong capital markets acumen.